A major trial, the EMPA-REG Outcome study, Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes enrolled patients with type 2 diabetes who were also at high risk of cardiovascular events such as strokes or heart attacks to take Empagliflozin and monitor if there were any beneficial effects in this group
Th khng lu bn s c mt ln da nch trng sng, mn mng v khng cn mi hi na
rather, it exemplifies how endogenous peptide systems with pleiotropic signaling can be rendered clinically tractable through advances in peptide stabilization, pharmacokinetics, receptor bias, and dosing strategies
Understanding injectable versus oral peptide differences also helps contextualize why reconstitution skills matter for the injectable route specifically
Henriksen MM, Andersen HU, Thorsteinsson B, Pedersen-Bjergaard U (2018) Hypoglycemic exposure and risk of asymptomatic hypoglycemia in type 1 diabetes assessed by continuous glucose monitoring